Skip to content
Skip to content

Guide

How to Start a Longevity Telehealth Program

Longevity is the most demand-rich, legality-fraught niche in DTC telehealth: audiences want protocols, optimization, and the substances they heard about on podcasts, and a meaningful share of that wishlist cannot be lawfully sold at all. The programs that last invert the category's instincts: they are labs-and-monitoring businesses with a conservative, certifiable Rx menu, not pill catalogs with a longevity logo. This guide walks the menu question first (because it decides your certifiability, your ad eligibility, and your risk profile before anything else exists), then the business model that actually compounds, current as of September 2026.

8 min readUpdated September 7, 2026

The menu question decides everything, so answer it first

Every longevity founder arrives with a wishlist, and the first honest exercise is sorting it into three piles. Lawful and ordinary: established prescription medications a clinician can appropriately prescribe where indicated, plus the non-Rx foundations (labs, coaching, supplements sold as supplements with supplement-grade claims). Lawful within narrow postures: compounded formulations, NAD+ included, which exist under 503A patient-specific postures whose written legal basis is your diligence item, verified with the pharmacy and revisited on schedule. Not lawful to sell: the research-chemical peptide world, where 'not for human consumption' labels are evidence rather than loopholes, and where many podcast-famous compounds sit outside any lawful dispensing pathway at all.

The sorting is not optional, because reviewers do it for you: certification examines your whole catalog, and problem products sink storefronts regardless of how compliant the rest is. Our LegitScript problem-products guide names the categories; the practical rule is that a longevity menu is built from the first pile, adds the second only with written bases in hand, and treats the third as a marketing constraint (you may discuss the science of things you do not sell; you may not sell them).

The longevity menu rule: sort every wishlist item into lawful-and-ordinary, lawful-within-written-postures, or not-lawful-to-sell, before building anything. Certification reviewers audit the catalog, and one problem product outweighs a hundred compliant pages.

The business model that actually lasts

Strip the hype and longevity is the best-shaped subscription business in telehealth: the product is measurement and iteration (baseline labs, clinician review, a protocol, follow-up labs, adjustment), which means the value visibly compounds the longer a patient stays. That is the inverse of one-and-done categories, and it is why the durable programs sell the loop (testing, clinical judgment, tracking, adjustment) with medications as one clinician-directed component rather than the headline.

Designed that way, the model also solves the category's marketing problem: you are not promising lifespan (an unprovable claim no lawyer will bless); you are selling visibility and clinician-guided iteration, which is honest, substantiable, and exactly what the sophisticated end of the audience wants anyway. Expectation-setting does double duty here: patients who understand they bought a process retain; patients promised transformation churn at the first plateau.

The clinical and structural layer

Nothing about the longevity label changes the triangle: licensed clinicians make every prescribing decision individually, licensed pharmacies dispense, and your brand owns the program around them. The category's specific clinical demands are labs logistics (draw networks, result routing, clinician review time) and protocol governance (who writes the protocols, which clinician owns their review, how off-label questions are handled clinically rather than promotionally, since off-label promotion by the business is its own line not to cross).

The structural build is the standard one (MSO chassis for non-clinician founders, operated rails or assembly), with one category-specific note: because longevity menus flirt with compounded postures, the pharmacy-diligence muscle this site documents everywhere is not a later chapter here; it is the first hire's job description.

Marketing longevity without marketing trouble

The claim rules bite harder in this category because the audience vocabulary is inherently promissory: optimization, reversal, anti-aging. The compliant register is process and measurement language (test, review, adjust; what the markers are and why clinicians watch them) with mechanism education where evidence supports it, and zero outcome promises, zero lifespan claims, zero equivalence claims for compounded products, with the compounded disclosure present wherever those products are substantively discussed: compounded medications are not FDA approved, are prescribed at a licensed clinician's discretion, and not all patients qualify.

Ad eligibility follows the same chain as every Rx category (certification first, platform approvals after), and the menu question returns here too: the certifiable catalog is also the advertisable one, which is the practical argument that wins the wishlist debate with your own marketing team.

Who this niche fits, and where EmbedCare sits

Longevity fits operators with patient audiences that skew data-curious (fitness, biohacking-adjacent wellness, executive health) and founders willing to sell the honest product: measurement, clinical judgment, iteration. It punishes founders who came for the peptide margins; the business-ideas guide files it in the gated tier for exactly that reason, and the fix is the menu discipline above, not cleverness.

On EmbedCare, longevity-adjacent care lines run where the catalog and rules support them, on the same operated stack as everything else: 50-state clinicians, owned pharmacy supply, certification-grade storefronts, and the retention machinery a measurement-loop business lives on. The menu conversation (what your wishlist sorts into, and what a certifiable longevity program looks like for your audience) is the right first demo conversation, and we will have the honest version of it.

Frequently asked

How do I start a longevity or NAD+ telehealth business?
Menu first: sort every planned offering into lawful-and-ordinary prescriptions, compounded formulations available only under written 503A postures (NAD+ typically lives here), and the research-chemical world you cannot lawfully sell. Then build the standard structure (licensed clinicians making every prescribing decision, licensed pharmacy supply, your brand owning the program) around a labs-and-monitoring subscription model, with certification started early if you plan to advertise.
Can I legally sell peptides through a telehealth program?
Only the narrow subset with lawful dispensing pathways, and only via clinician prescribing and licensed pharmacy postures verified in writing; many podcast-famous peptides have no lawful route at all, and research-chemical sourcing is a violation with shipping. Certification reviewers audit your whole catalog, so one impermissible product endangers the entire storefront; our problem-products guide names the categories to check.
Is NAD+ legal to offer online?
NAD+ formulations exist as compounded products under patient-specific 503A postures, which means the diligence is the same as any compounded offering: the pharmacy's written current legal basis, individualized clinician prescribing, and the standard disclosures (compounded medications are not FDA approved, are prescribed at a licensed clinician's discretion, and not all patients qualify). Treat the posture as verify-and-revisit, not set-and-forget.
What makes a longevity program profitable?
The loop, not the pills: baseline labs, clinician review, protocol, follow-up measurement, and adjustment create a subscription whose value visibly compounds with tenure, which is the strongest retention shape in telehealth. Model it like any program (contribution per month times tenure minus acquisition) and let the measurement cadence, not medication margins, carry the story.
Can I market anti-aging results?
Market the process, never the outcome: testing, clinician-guided iteration, and mechanism education where evidence supports it. Lifespan and reversal promises are unsubstantiable health claims, compounded-product equivalence claims are named enforcement patterns, and the longevity vocabulary makes it easy to drift into both, which is why the compliant register is measurement language throughout.

Want pricing for your program, and the Rx menu that goes with this?

The partner overview in one email; a human follows up with pricing scoped to your program.

The fastest way to understand it is to see it running.